Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors
39 ASCT1 and ASCT2, which have mainly been studied in the context of glutamine dependence, are expressed at high levels in different cancer types, 40,41,42 prompting these transporters to be considered putative therapeutic targets in cancer, with different inhibitors currently under investigation
Understanding IV therapy before and after each session gives you the confidence to prepare well, stay comfortable during treatment, and take care of yourself afterward
Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA
[DOI] [PMC free article] [PubMed] [Google Scholar] Ramakrishnan M, Papolu PK, Satish L, Vinod KK, Wei Q, Sharma A.Emamverdian A, Zou LH, Zhou M